Document Detail


Association between pulmonary and digestive infections in patients receiving gastric acid-lowering medications for a long duration.
MedLine Citation:
PMID:  12963554     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
OBJECTIVES: To evaluate the frequency of pulmonary and digestive infections in a population of disabilitated patients receiving gastric acid-lowering medications for a long duration. METHODS: Cases underwent gastric acid-lowering medications for at least 4 years and controls were matched on type of handicap, aetiologies of handicap, sex and age and didn't receive gastric acid-lowering medications. For each patient, the following data were collected: age, sex, aetiology of disabilitation, type of gastric acid-lowering medications (histamine receptor H2 antagonists or proton pump inhibitors), occurrence of gastric or oesophageal pathology, nasogastric tube or gastrostomy device, motor handicap, number of digestive infections and number of pulmonary infections during the last 5 years. RESULTS: Total rate of infections was significantly more frequent in patients receiving gastric acid lowering medications than in patients who did not receive gastric acid-lowering medications (p = 0.035). Pulmonary infections were significantly more frequent in patients receiving gastric acid-lowering medications than in those who did not receive gastric acid-lowering medications (p < 0.05). The rate of digestive infections was not influenced by acid-suppressive treatments. CONCLUSION: Oesophagitis may lead to complications and requires gastric acid-lowering medications; in fact these drugs promote bacterial development and subsequently increase the risk of pulmonary infections.
Authors:
M C Rousseau; A Catala; J Blaya
Related Documents :
8930574 - Proton-pump inhibitors are the treatment of choice in acid-related disease.
17405344 - Anti-ulceral and anti-oxidative properties of "earthworm paste" of lampito mauritii (ki...
16369224 - Intravenous proton pump inhibitor therapy: a rationale for use.
2365184 - Thermodynamic effects of bile acids in the stomach.
21569104 - Omega-3 polyunsaturated fatty acids: photoprotective macronutrients.
1501074 - Identification of 5-ethyl-5-(2-methylbutyl)barbituric acid as an impurity of manufactur...
Publication Detail:
Type:  Clinical Trial; Controlled Clinical Trial; Journal Article    
Journal Detail:
Title:  Brain injury : [BI]     Volume:  17     ISSN:  0269-9052     ISO Abbreviation:  Brain Inj     Publication Date:  2003 Oct 
Date Detail:
Created Date:  2003-09-09     Completed Date:  2004-01-13     Revised Date:  2004-11-17    
Medline Journal Info:
Nlm Unique ID:  8710358     Medline TA:  Brain Inj     Country:  England    
Other Details:
Languages:  eng     Pagination:  883-7     Citation Subset:  IM    
Affiliation:
Hôpital San Salvadour, Assistance Publique Hôpitaux de Paris, Hyères, France. marie-christine.rousseau@ssl.ap-hop-paris.fr
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Adolescent
Adult
Antacids / adverse effects*
Bacterial Infections / chemically induced*,  metabolism
Digestive System Diseases / chemically induced*,  metabolism
Female
Gastric Acid / metabolism
Humans
Lung Diseases / chemically induced*,  metabolism
Male
Mental Disorders / complications
Respiratory Tract Infections / chemically induced,  metabolism
Retrospective Studies
Chemical
Reg. No./Substance:
0/Antacids

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Subject ordered pointing task performance following severe traumatic brain injury in adults.
Next Document:  Diagnosing depression in persons with brain injuries: a look at theories, the DSM-IV and depression ...